Login / Signup

Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer.

Pierre NahonMaxime RonotOlivier SutterPierre-André NatellaSamia BaloulIsabelle Durand ZaleskiEtienne Audureau
Published in: BMJ open (2024)
Clinical trial number (ClinicaTrials.gov) NCT05095714.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • magnetic resonance imaging
  • public health
  • systematic review
  • contrast enhanced
  • phase ii
  • study protocol
  • open label
  • diffusion weighted imaging
  • double blind